CD86 and leukemia: In this study, we collected LEXs derived from mouse leukemia L1210 cells transduced with a lentiviral vector encoding CD80 and CD86 and investigated the anti-leukemia immunity of LEX-CD8086-targeted CD4+ T cells in vitro and in vivo.